Cellosaurus logo
expasy logo

Cellosaurus PC346Enza (CVCL_RA54)

[Text][XML][JSON]
Cell line name PC346Enza
Accession CVCL_RA54
Resource Identification Initiative To cite this cell line use: PC346Enza (RRID:CVCL_RA54)
Comments Selected for resistance to: ChEBI; CHEBI_68534; Enzalutamide (Xtandi; MDV-3100).
Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
Disease Prostate carcinoma (NCIt: C4863)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_4883 (PC-346C)
Sex of cell Male
Age at sampling Age unspecified
Category Cancer cell line
Publications

PubMed=24200698; DOI=10.1016/j.ejca.2013.09.026
Robert J. van Soest, Martin Eduard van Royen, Ellen S. de Morree, Jan Matthijs Moll, Wilma J. Teubel, Erik A.C. Wiemer, Ron H.J. Mathijssen, Rick de Wit, Wytske M. van Weerden;
Cross-resistance between taxanes and new hormonal agents abiraterone and enzalutamide may affect drug sequence choices in metastatic castration-resistant prostate cancer.
Eur. J. Cancer 49:3821-3830(2013)

Cross-references
Encyclopedic resources Wikidata; Q54938577
Entry history
Entry creation05-Mar-2018
Last entry update19-Dec-2024
Version number7